Immunovant IMVT
NASDAQ IMVT
$28.27 -0.32 (-1.12%)
As of: Oct 21, 2026 · 1:32 PM EDT

Immunovant (IMVT) Non-Current Debt (2019 - 2021)

Updated

Immunovant (IMVT) reported Non-Current Debt of -$50,000 for fiscal Q2 2020 (quarter ended Sep 30, 2019).

Analysis

Immunovant (IMVT) Non-Current Debt (2019 - 2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,134.50 Bn 1,103.09 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 616.20 Bn 534.73 Bn 17.26 Bn 37.34 Bn
3 AbbVie 500.82 Bn 473.93 Bn 12.70 Bn 62.48 Bn
4 Merck 367.31 Bn 321.69 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 297.77 Bn 261.76 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 261.35 Bn 235.04 Bn 12.86 Bn 23.68 Bn
7 Amgen 235.40 Bn 190.80 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 190.59 Bn 164.79 Bn 6.22 Bn 23.83 Bn
9 Pfizer 169.39 Bn 116.04 Bn 10.94 Bn 60.50 Bn
10 Immunovant 5.81 Bn 2.59 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 3.19 Mn
Dec 31, 2020 -134,000.00
Sep 30, 2020 -202,000.00
Jun 30, 2020 -2.85 Mn
Mar 31, 2020 27.09 Mn
Dec 31, 2019 -27.09 Mn
Sep 30, 2019 -2.50 Mn
API Access

Immunovant Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=IMVT&period=max&api_key=YOUR_API_KEY